期刊文献+

WHO淋巴组织肿瘤新分类的学习与思考 被引量:1

New WHO classification of lymphoid neoplasms: understanding and consideration
下载PDF
导出
摘要 The latest version of new WHO classification of lymphoid neoplasms is a comprehensive and distinct opinion of lymphoid neoplasms , and maybe put an end to the controversy held in this field for a long time. The new classification defines the neoplasm categories according to the principle that the classification should be based on the real entities of diseases and should contain the morphology, immunophenotypes, genetic alterations and clinical features rather than simply emphasize the pure morphologic presentations. The new subtyping of lymphoid cancers provides a correct framework for malignant lymphoma, and also represents a new paradigm in disease classification.So far the accumulated experiences have demonstrated that the new classification is reproducible and practical. However, it remains to determine how the variants of lymphomas relate to their clinical prognostic factors, such as international prognostic index and individual difference, since the current treatment approach relays on the types of lymphomas. The diagnosis, treatment and researches of lymphomas in China are also discussed. The latest version of new WHO classification of lymphoid neoplasms is a comprehensive and distinct opinion of lymphoid neoplasms , and maybe put an end to the controversy held in this field for a long time. The new classification defines the neoplasm categories according to the principle that the classification should be based on the real entities of diseases and should contain the morphology, immunophenotypes, genetic alterations and clinical features rather than simply emphasize the pure morphologic presentations. The new subtyping of lymphoid cancers provides a correct framework for malignant lymphoma, and also represents a new paradigm in disease classification.So far the accumulated experiences have demonstrated that the new classification is reproducible and practical. However, it remains to determine how the variants of lymphomas relate to their clinical prognostic factors, such as international prognostic index and individual difference, since the current treatment approach relays on the types of lymphomas. The diagnosis, treatment and researches of lymphomas in China are also discussed.
作者 李挺 尹洪芳
出处 《北京大学学报(医学版)》 CAS CSCD 北大核心 2003年第1期94-98,共5页 Journal of Peking University:Health Sciences
基金 国家自然科学基金 (3 0 2 70 5 17)~~
关键词 WHO 淋巴组织肿瘤 新分类 Neoplasms/class Lymphoid tissue World Health Organization
  • 相关文献

参考文献13

  • 1[1]Harris NJ, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: A proposal from the international lymphoma study group[J]. Blood, 1994, 84:1361-1391
  • 2[2]Harris NJ, Jaffe ES, Diebold J, et al. The World Health Organization classification of hematological malignancies report of Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997[J]. Mod Pathol, 2000, 13:193-207
  • 3[3]Harris NJ, Jaffe ES, Diebold J, et al. The World Health Organization classification of neoplastic diseases of the haematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997[J]. Histopathology, 2000, 36:69-86
  • 4[4]Jaffe ES, Harris NL, Stein H, eds.Tumors of haematopoietic and lymphoid tissues. Pathology and Genetics. World Health Organization Classification of Tumours[M]. Lyon: IARC Press, 2001.81-87
  • 5[5]Hermans J, Krol AD, van Groningen K, et al. International prognostic index for aggressive Non-Hodgkin's lymphoma is valid for all malignancy grades[J]. Blood, 1995, 86:1460-1463
  • 6[6]Sen F, Vega F, Medeiros J. Molecular genetic methods in the hematologic neoplasms[J]. Sem in Diag Patholo, 2002, 19:72-93
  • 7[7]Alizadeh AA. The lymphochip: a specialized cDNA microarray for the genomic-scale analysis of gene expression in normal and malignant lymphocytes[J].Cold Spring Harb Symp Quant Biol, 1999, 64:71-78
  • 8[8]The Non-Hodgkin's Lymphoma Classification Project. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma[J]. Blood, 1997, 89:3909-3918
  • 9[9]Alizadeh AA, Eisen MB, Davis RE, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling[J]. Nature, 2000, 403:503-511
  • 10[10]Hiddemann W, Longo DL, Coiffier B, et al. Lymphoma classification-the gap between biology and clinical management is closing[J]. Blood, 1996, 88:4085-4089

同被引文献12

  • 1Naresh KN, Srinivas V, Soman S. Distribution of various subtypes of non-Hodgkin's lymphoma in India: a study of 2773 lymphomas using R. E. A. L and WHO Classifications. Ann Oncol, 2000, 11: S63-67.
  • 2Lee SS, Cho K J, Kim CW, et al. The clinicopathological analysis of 501 non-Hodgkin's lymphomas in Korea according to the revised European-American classification of lymphoid neoplasms.Histopathology, 1999,35:345-354.
  • 3Chuang SS, Lin CN, Li CY. Malignant lympboma in southern Taiwan according to the revised European-American classification of lymphoid neoplasms. Cancer, 2000, 89: 1586-1592.
  • 4Chan JK. the new World Health Organization classification of lymphomas: The past, the present and the future. Hematol Oncol,2001,19: 129-150.
  • 5Alizadeh AA, Eisen MB, Davis RE, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling.Nature, 2000, 403: 503-511.
  • 6Hermans J, Krol AD, van Groningen K, et al. International prognostic index for aggressive non-Hodgkin's lymphoma is valid for all malignancy grades. Blood, 1995, 86: 1460-1463.
  • 7Sen F, Vega F, Medeiros LJ. Molecular genetic methods in the diagnosis hematologic neoplasms. Semin Diagn Pathol, 2002, 19:72-93.
  • 8Waston P, Wood KM, Lodge A, et al. Monoclonal antibodies recognizing CD5, CD10 and CD23 in formalin-fixed, paraffinembedded tissue: production and assessment of their value in the diagnosis of small B-cell lymphomas. Histopathology, 2000, 36:145-150.
  • 9Jaffe ES, Krenacs L, Kumar S, et al. Extranodal peripheral T-cell and NK-cell neoplasms. Am J Clin Pathol, 1999, 111 ( suppl 1 ):S46-55.
  • 10von Wasielewski R, Werner M, Fischer R, et al. Lymphocyte predominant Hodgkin's disease. An immumohistochemical analysis of 208 reviewed Hodgkin's disease cases from the German Hodgkin Study Group. Am J Pathol, 1997, 150: 793-803.

引证文献1

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部